EMA Authorised: Rekovelle (follitropin delta) — Ferring Pharmaceuticals A/S

View source ↗

Summary

EMA authorised Rekovelle (follitropin delta) for the treatment of anovulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation

Drugs mentioned

• Rekovelle (follitropin delta)

Snippet

Status: Authorised. Therapeutic area: Anovulation. MAH: Ferring Pharmaceuticals A/S. Decision date: 20/07/2023